Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 21/3/19941 min de lectura
Vaginal Drug Products for Over-the-Counter Human Use; Withdrawal of Advance Notice of Proposed Rulemaking; Correction
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is correcting a notice of withdrawal of advance notice of proposed rulemaking that appeared in the Federal Register of February 3, 1994 (59 FR 5226). The document announced the withdrawal of the advance notice of proposed rulemaking that would have established conditions under which over-the-counter (OTC) vaginal drug products are generally recognized as safe and effective and not misbranded. The document was published with some errors. This document corrects those errors.
Idioma original de la fuente: Federal Register — Health and Human ServicesAbrir el comunicado original →